CAS 1037543-26-2

Formel: C31H40O4

InChl: InChI=1S/C31H40O4/c1-7-10-29(32)34-22-26-15-17-27(18-16-26)35-30(33)21-24(3)12-8-11-23(2)14-19-28-25(4)13-9-20-31(28,5)6/h8,11-12,14-19,21H,7,9-10,13,20,22H2,1-6H3/b12-8+,19-14+,23-11+,24-21+

InChI Key: GDELUZOQMHQHNF-PFLGVXPYSA-N

SMILES: CCCC(=O)OCC1=CC=C(C=C1)OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C2=C(CCCC2(C)C)C

Atra-ba hybrid

Kontrolliertes Produkt

CAS: 1037543-26-2

Please enquire for more information about Atra-ba hybrid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formel: C₃₁H₄₀O₄

Reinheit: Min. 95%

Molekulargewicht: 476.6 g/mol

Ref: 3D-MRB54326

ATRA-BA Hybrid

CAS: 1037543-26-2

ATRA-BA, a prodrug, releases ATRA and butyric acid to inhibit MDA-MB-231 and PC3 cancer cells with enhanced potency at 20 μM.

Formel: C₃₁H₄₀O₄

Farbe und Form: Solid

Molekulargewicht: 476.65

Ref: TM-T35629